|
[1]
|
Anders, H.J., Kitching, A.R., Leung, N. and Romagnani, P. (2023) Glomerulonephritis: Immunopathogenesis and Immunotherapy. Nature Reviews Immunology, 23, 453-471. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Gleeson, P.J., Benech, N., Chemouny, J., Metallinou, E., Berthelot, L., da Silva, J., et al. (2024) The Gut Microbiota Posttranslationally Modifies IgA1 in Autoimmune Glomerulonephritis. Science Translational Medicine, 16, eadl6149. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Hu, J., Ke, R., Teixeira, W., et al. (2023) Global, Regional, and National Burden of CKD Due to Glomerulonephritis from 1990 to 2019: A Systematic Analysis from the Global Burden of Disease Study 2019. Clinical Journal of the American Society of Nephrology, 18, 60-71. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Dou, L.L., Zhang, X.Y., Liu, D., et al. (2024) Role of Traditional Chinese Medicine for the Treatment of Lupus nephritis: Mechanisms and Applications. Alternative Therapies, Health and Medicine, 30, 154-165.
|
|
[5]
|
高家荣, 施苗苗, 陈浩, 等. 芪藤消浊颗粒介导miR-339-5p对慢性肾小球肾炎大鼠炎症指标的影响[J]. 中国临床药理学与治疗学, 2022, 27(4): 457-465.
|
|
[6]
|
郑舒文, 王柏森, 李志明, 等. 基于网络药理学及分子对接探讨参苓白术散对慢性肾小球肾炎和抑郁症异病同治的作用机制[J]. 中国医科大学学报, 2022, 51(9): 804-809.
|
|
[7]
|
杜世拔, 李国政, 卢微嫒, 等. 健脾固肾方联合常规治疗对脾肾亏虚型早期糖尿病肾病患者的临床疗效[J]. 中成药, 2021, 43(3): 649-653.
|
|
[8]
|
张文杰, 赖星海, 陈佳薇. 山药多糖治疗肥胖糖尿病肾病大鼠的效果观察及对其肾功能和肠道微生态的影响[J]. 中国微生态学杂志, 2021, 33(1): 37-42.
|
|
[9]
|
国家药典委员会. 中华人民共和国药典: 2020 年版. 一部[M]. 北京: 中国医药科技出版社, 2020: 70-71.
|
|
[10]
|
Hu, P., Liang, Q.L., Luo, G.A., et al. (2005) Multi-Component HPLC Fingerprinting of Radix Salviae Miltiorrhizae and Its LC-MS-MS Identification. Chemical and Pharmaceutical Bulletin, 53, 677-683. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
许蕊蕊, 周利朋, 刘欣悦, 等. 山药化学成分、药理作用研究进展及质量标志物预测[J]. 中国现代中药, 2025, 27(8): 1564-1574.
|
|
[12]
|
Zhang, X., Mei, D., Zhang, L. and Wei, W. (2020) Src Family Protein Kinase Controls the Fate of B Cells in Autoimmune Diseases. Inflammation, 44, 423-433. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Huang, Y., Zhao, X., Zhang, Q., Yang, X., Hou, G., Peng, C., et al. (2023) Novel Therapeutic Perspectives for Crescentic Glomerulonephritis through Targeting Parietal Epithelial Cell Activation and Proliferation. Expert Opinion on Therapeutic Targets, 27, 55-69. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Shi, D., Li, Y., Shi, X., Yao, M., Wu, D., Zheng, Y., et al. (2023) Transcriptional Expression of CXCL10 and STAT1 in Lupus Nephritis and the Intervention Effect of Triptolide. Clinical Rheumatology, 42, 539-548. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Cai, Z., Zhang, S., Wu, P., Ren, Q., Wei, P., Hong, M., et al. (2021) A Novel Potential Target of IL-35-Regulated JAK/STAT Signaling Pathway in Lupus Nephritis. Clinical and Translational Medicine, 11, e309. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Tang, Y., Zhang, J., Wang, Z. and Dong, X. (2025) Potential Modulatory Effects of Hesperidin on the JAK/STAT Pathway in Mesangial Proliferative Glomerulonephritis. Chemical Biology & Drug Design, 105, e70032. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Park, J.Y., Yoo, K.D., Bae, E., Kim, K.H., Lee, J.W., Shin, S.J., et al. (2022) Blockade of STAT3 Signaling Alleviates the Progression of Acute Kidney Injury to Chronic Kidney Disease through Antiapoptosis. American Journal of Physiology-Renal Physiology, 322, F553-F572. [Google Scholar] [CrossRef] [PubMed]
|